AMD vs MRK: Which Is the Better Buy?
Side-by-side comparison of Advanced Micro Devices, Inc. and Merck & Co., Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-06.
Advanced Micro Devices, Inc. · Technology
$555.79
+24.0% upside to fair value
Grade B
VS
Merck & Co., Inc. · Healthcare
$113.87
-12.1% upside to fair value
Grade D
High Quality
QuantHub Verdict
AMD has more upside to fair value
(+24.0%).
MRK trades at a lower forward P/E
(32.0x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
AMD |
MRK |
| Current Price |
$555.79 |
$113.87 |
| Fair Value Estimate |
$689.29 |
$100.14 |
| Upside to Fair Value |
+24.0%
|
-12.1%
|
| Market Cap |
$906.3B |
$281.2B |
| Forward P/E |
177.7x
|
32.0x
|
| EV / EBITDA |
110.2x
|
17.3x
|
| Price / Sales |
24.1x
|
4.3x
|
| Price / FCF |
105.3x
|
19.9x
|
| Revenue Growth YoY |
+37.8%
|
+4.3%
|
| Gross Margin |
50.3%
|
75.9%
|
| Operating Margin |
11.7%
|
27.6%
|
| Return on Equity |
8.1%
|
17.9%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
0.95%
|
5.02%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Advanced Micro Devices, Inc. (AMD) is a leading semiconductor company specializing in high-performance CPUs and GPUs with a competitive moat driven by technical innovation and ecosystem scale. Under CEO Dr. Lisa Su's leadership since 2014, AMD has transformed from a $2 billion market cap to over $90 billion, gaining significant market share from Intel and Nvidia. The company reported $34.6 billio…
Merck & Co., Inc. is a leading global healthcare company specializing in pharmaceuticals, vaccines, and animal health products. Its business quality is high, supported by a durable competitive moat anchored in the dominant global position of Keytruda in PD-1/PD-L1 oncology, a strong vaccines portfolio including Gardasil, and scale in R&D and manufacturing. The company benefits from a seasoned lea…
Accumulation Zones
| Metric |
AMD |
MRK |
| Zone Low |
$516.97 |
$75.11 |
| Zone High |
$585.90 |
$85.12 |
| In Buy Zone? |
Yes
|
No
|